Interventions to help patients withdraw from depression drugs: A systematic review
International Journal of Risk & Safety in Medicine · 2024
DOI: 10.3233/jrs-230011 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Risk & Safety in Medicine, 2024. Verfasst von Peter C Gøtzsche und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Scientific Freedom, Hørsholm, Denmark. Hauptthemen laut MEDLINE: Antidepressive Agents, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Depression drugs can be difficult to come off due to withdrawal symptoms. Gradual tapering with tapering support is needed to help patients withdraw safely. OBJECTIVE: To review the withdrawal success rates, using any intervention, and the effects on relapse/recurrence rates, symptom severity, quality of life, and withdrawal symptoms. METHODS: Systematic review based on PubMed and Embase searches (last search 4 October 2022) of randomised trials with one or more treatment arms aimed at helping patients withdraw from a depression drug, regardless of indication for treatment. We calculated the mean and median success rates and the risk difference of depressive relapse when discontinuing or continuing depression drugs. RESULTS: We included 13 studies (2085 participants). Three compared two withdrawal interventions and ten compared drug discontinuation vs. continuation. The success rates varied hugely between the trials (9% to 80%), with a weighted mean of 47% (95% confidence interval 38% to 57%) and a median of 50% (interquartile range 29% to 65%). A meta-regression showed that the length of taper was highly predictive for the risk of relapse ( P = 0.00001). All the studies we reviewed confounded withdrawal symptoms with relapse; did not use hyperbolic tapering; withdrew the depression drug too fast; and stopped it entirely when receptor occupancy was still high. CONCLUSION: The true proportion of patients on depression drugs who can stop safely without relapse is likely considerably higher than the 50% we found.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Scientific Freedom, Hørsholm, Denmark.
Zitieren
APA
Gøtzsche, P. C., & Demasi, M. (2024). Interventions to help patients withdraw from depression drugs: A systematic review. International Journal of Risk & Safety in Medicine. https://doi.org/10.3233/jrs-230011
Vancouver
Gøtzsche PC, Demasi M. Interventions to help patients withdraw from depression drugs: A systematic review. International Journal of Risk & Safety in Medicine. 2024. doi:10.3233/jrs-230011
BibTeX
@article{Gtzsche2024,
author = {Gøtzsche, Peter C and Demasi, Maryanne},
title = {Interventions to help patients withdraw from depression drugs: A systematic review},
journal = {International Journal of Risk & Safety in Medicine},
year = {2024},
doi = {10.3233/jrs-230011}
}
EUVIMED